Security
Nexalin Technology Inc. Warrant · NXLIW
NXLIWNASDAQWarrantHistorical · closed Sep 19, 2025CIK 1527352Updated Nov 9, 2026
Current security for this SEC filerNXL · NASDAQ
NXLIW price & chart
Historical security
This listing closed Sep 19, 2025. Live provider charts are shown only for current listings.
Current security: NXL
About the company
We are a medical device company engaged in the design and development of innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. We developed an easy-to-administer medical device — referred to as “Generation 1” or “Gen-1” — that utilizes bioelectronic medical technology to treat anxiety, insomnia and depression without the need for drugs or psychotherapy. Our original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit a waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (the “FDA”) as a Class II device.
In the news
No coverage from other publishers is available.
Seeking Alpha
Recent filings
Show 5 more recent filings
Entry into a Material Definitive Agreement · Regulation FD Disclosure
Items 1.01, 7.01, 9.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Items 3.01
S-8 filing
S-1 filing
SCHEDULE 13D - filed by Greenlight Ventures, LLC regarding Nexalin Technology, Inc.
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 5,125,940Source | 5,257,182Source | 3,004,179Source | 6,563,982Source | 1,563,126Source | 3,694,633Source | 2,900,111Source | 2,834,210Source | 4,635,319Source | 4,222,732Source | 3,631,916Source | 7,432,136Source |
| Property, Plant and Equipment, NetUSD | — | — | 42,432Source | — | — | — | — | — | — | — | — | 503Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 308,562Source | 248,942Source | 399,501Source | 294,871Source | 226,077Source | 359,310Source | 279,520Source | 169,174Source | 336,049Source | 260,727Source | 95,219Source | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 590,075Source | 81,421Source | 1,004,958Source | 431,320Source | 848,796Source | 1,207,895Source | 622,029Source | 546,255Source | 654,783Source | 574,485Source | 580,230Source | 162,743Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 7,925Source | 15,171Source | 52,930Source | 59,841Source | 11,720Source | 43,004Source | 14,479Source | 3,666Source | 81,571Source | 13,043Source | 9,369Source | 4,875Source |
| Inventory, NetUSD | 160,225Source | 158,375Source | 233,462Source | 172,974Source | 145,141Source | 179,489Source | 175,253Source | 153,668Source | 131,473Source | 174,578Source | 156,420Source | 154,370Source |
| Assets, CurrentUSD | 4,817,378Source | 4,907,589Source | 1,862,106Source | 6,269,111Source | 1,182,143Source | 3,290,154Source | 2,620,591Source | 2,563,253Source | 4,299,270Source | 3,961,141Source | 3,429,892Source | 7,425,462Source |
| Prepaid Expense and Other Assets, CurrentUSD | 296,551Source | 140,425Source | 570,756Source | 243,511Source | 176,486Source | 359,176Source | 379,780Source | 261,977Source | 363,014Source | 293,597Source | 315,670Source | 272,282Source |
| Operating Lease, Right-of-Use AssetUSD | — | — | — | — | — | — | — | — | — | — | 496Source | 6,171Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 357,524Source | 299,389Source | 1,484,756Source | 600,584Source | 212,104Source | 808,364Source | 574,736Source | 507,223Source | 887,333Source | 546,694Source | 425,281Source | 1,953,449Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 18,190Source | 12,862Source | 22,003Source | 17,418Source | 7,587Source | 20,581Source | 13,328Source | 7,437Source | 19,186Source | 13,304Source | 7,437Source | 7,287Source |
| Additional Paid in CapitalUSD | 95,241,723Source | 86,757,212Source | 98,700,839Source | 94,159,705Source | 80,707,134Source | 97,829,443Source | 88,945,298Source | 80,399,001Source | 96,595,806Source | 88,308,478Source | 80,237,652Source | 77,824,427Source |
| Retained Earnings (Accumulated Deficit)USD | -90,490,866Source | -81,811,956Source | -97,203,419Source | -88,214,555Source | -79,363,699Source | -94,964,249Source | -86,633,568Source | -78,079,206Source | -92,867,412Source | -84,645,231Source | -77,038,049Source | -72,389,340Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -631Source | -325Source | — | 830Source | — | 494Source | 317Source | -245Source | 406Source | -513Source | -405Source | 36,313Source |
| Stockholders' Equity Attributable to ParentUSD | 4,768,416Source | 4,957,793Source | 1,519,423Source | 5,963,398Source | 1,351,022Source | 2,886,269Source | 2,325,375Source | 2,326,987Source | 3,747,986Source | 3,676,038Source | 3,206,635Source | 5,478,687Source |
| Liabilities and EquityUSD | 5,125,940Source | 5,257,182Source | 3,004,179Source | 6,563,982Source | 1,563,126Source | 3,694,633Source | 2,900,111Source | 2,834,210Source | 4,635,319Source | 4,222,732Source | 3,631,916Source | 7,432,136Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 357,524Source | 299,389Source | 1,484,756Source | 600,584Source | 212,104Source | 808,364Source | 574,736Source | 507,223Source | 887,333Source | 546,694Source | 425,281Source | 1,948,986Source |
| Operating Lease, Liability, CurrentUSD | — | — | — | — | — | — | — | — | — | — | 4,463Source | 50,797Source |
| Accounts Payable, CurrentUSD | 67,493Source | 166,542Source | 239,448Source | 240,580Source | 87,138Source | 168,099Source | 181,394Source | 151,510Source | 244,579Source | 155,949Source | 159,534Source | 658,367Source |
| Operating Lease, Liability, NoncurrentUSD | — | — | — | — | — | — | — | — | — | — | — | 4,463Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 290,031Source | 132,847Source | 858,504Source | 360,004Source | 124,966Source | 640,265Source | 393,342Source | 355,713Source | 642,754Source | 390,745Source | 261,284Source | 539,822Source |
| Deferred Compensation EquityUSD | — | — | — | — | — | — | — | — | 589,000Source | 323,000Source | 215,000Source | 23,000Source |
| Short-term InvestmentsUSD | 3,762,602Source | 4,512,197Source | — | 5,361,465Source | — | 1,500,590Source | 1,429,050Source | 1,597,687Source | 3,068,429Source | 2,905,438Source | 2,368,203Source | 6,831,192Source |
| Other Assets, Noncurrent | — | — | — | — | —Source | — | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -2,276,311Source | -2,448,257Source | -2,239,170Source | -1,580,987Source | -2,096,837Source | -1,988,337Source | -8,222,181Source | -7,607,182Source | — | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 478,611Source | 636,844Source | 3,123,263Source | 3,560,509Source | 2,413,375Source | 270,670Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -755Source | 1,040Source | 33,722Source | — | 880Source | -253Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 48,016Source | 675Source | -26,725Source | 18,158Source | 7,812Source | 142,852Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -76,480Source | 25,445Source | 88,629Source | -3,585Source | -238,833Source | -46,107Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -1,712,988Source | -1,426,214Source | -4,957,658Source | -3,944,390Source | -3,835,384Source | -2,215,699Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 1,509,679Source | 1,473,758Source | -131,991Source | -577,539Source | 4,452,872Source | -6,794,879Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 756,421Source | — | 5,169,947Source | 4,516,184Source | -200,000Source | 8,511,543Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 590,075Source | 81,421Source | 1,004,958Source | 431,320Source | 1,207,895Source | 622,029Source | 654,783Source | 574,485Source | 580,230Source | 162,743Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 0Source | — | — | — |
| Additional Financial Items | ||||||||||||
| AmortizationUSD | — | — | 5,473Source | 4,211Source | 20,325Source | 5,126Source | 6,736Source | 4,786Source | 21,537Source | 15,107Source | 3,751Source | — |
| Amortization of Intangible AssetsUSD | — | — | 5,473Source | 4,211Source | 13,000Source | 5,125Source | 6,736Source | 4,786Source | 21,538Source | — | — | — |
| DepreciationUSD | — | — | — | — | — | — | 4,107Source | — | — | — | 503Source | 535Source |
| Gain (Loss) on Sale of InvestmentsUSD | — | — | 46,774Source | 56,250Source | 8,016Source | 32,438Source | 21,025Source | 20,119Source | 126,940Source | 130,110Source | 231,880Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | — | 615,000Source | — |
| General and Administrative ExpenseUSD | — | — | 779,900Source | 547,606Source | 852,838Source | 687,011Source | 801,904Source | 622,948Source | 3,132,723Source | 2,553,459Source | — | — |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | — | — | — |
| Inventory Write-downUSD | — | — | — | — | — | — | — | — | 16,380Source | 0Source | 5,762Source | 19,892Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -2,276,311Source | -2,448,257Source | -2,239,170Source | -1,580,987Source | -2,096,837Source | -1,988,337Source | -8,222,181Source | -7,607,182Source | -4,648,709Source | -1,697,816Source |
| Nonoperating Income (Expense)USD | — | — | 69,320Source | 60,101Source | 8,145Source | 39,871Source | 23,065Source | 23,936Source | 169,748Source | 142,613Source | 1,047,587Source | 135,215Source |
| Operating ExpensesUSD | — | — | 2,359,832Source | 2,531,854Source | 2,256,212Source | 1,668,608Source | 2,133,035Source | 2,038,682Source | 8,631,155Source | 7,886,774Source | 5,781,356Source | 2,791,176Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | 4,646,397Source | 4,516,184Source | — | 8,545,270Source |
| Unrealized Gain (Loss) on InvestmentsUSD | — | — | -1,461Source | -325Source | -406Source | 513Source | 88Source | 830Source | 919Source | -108Source | -36,718Source | — |
| Depreciation and amortization | — | — | — | — | —Source | — | —Source | — | — | — | — | — |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | —Source | —Source | —Source | —Source | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 18,149Source | 36,031Source | 12,161Source | 70,588Source | 14,950Source | 41,015Source | 301,647Source | 168,721Source | 110,748Source | 1,321,357Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Selling, General and Administrative ExpenseUSD | — | — | 1,420,079Source | 1,796,811Source | 782,571Source | 893,836Source | 792,797Source | 929,220Source | 4,398,241Source | 4,228,986Source | 3,818,842Source | 1,491,739Source |
| Operating Income (Loss)USD | — | — | -2,345,631Source | -2,508,517Source | -2,247,315Source | -1,620,858Source | -2,119,902Source | -2,011,225Source | -8,390,881Source | -7,754,646Source | -5,696,296Source | -1,833,031Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -2,276,311Source | -2,448,416Source | -2,239,170Source | -1,580,987Source | -2,096,837Source | -1,987,289Source | -8,221,133Source | -7,612,033Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -2,276,311Source | -2,448,257Source | -2,239,170Source | -1,580,987Source | -2,096,837Source | -1,988,337Source | -8,222,181Source | -7,607,182Source | -4,648,709Source | -1,697,816Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.13Source | -0.23Source | -0.11Source | -0.1Source | -0.11Source | -0.15Source | -0.5Source | -0.83Source | -0.63Source | — |
| Earnings Per Share, DilutedUSD per share | — | — | -0.13Source | -0.23Source | -0.11Source | -0.1Source | -0.11Source | -0.15Source | -0.5Source | -0.83Source | -0.63Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 17,793,828Source | 10,847,476Source | 21,142,920Source | 15,718,149Source | 19,820,910Source | 13,307,319Source | 16,392,465Source | 9,215,772Source | 7,357,029Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 17,793,828Source | 10,847,476Source | 21,142,920Source | 15,718,149Source | 19,820,910Source | 13,307,319Source | 16,392,465Source | 9,215,772Source | 7,357,029Source | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 5,473Source | 4,211Source | 13,000Source | 5,125Source | 6,736Source | 4,786Source | 21,538Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 779,900Source | 547,606Source | 852,838Source | 687,011Source | 801,904Source | 622,948Source | 3,132,723Source | 2,553,459Source | — | — |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | — | — | — |
| Gross ProfitUSD | — | — | 14,201Source | 23,337Source | 8,897Source | 47,750Source | 13,133Source | 27,457Source | 240,274Source | 132,128Source | 85,060Source | 958,145Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -8,221,263Source | — | — | — |
| Interest ExpenseUSD | — | — | -2,288Source | -1,000Source | -129Source | -4,690Source | -34Source | -1,103Source | -8,240Source | -3,193Source | 38,835Source | 59,382Source |
| Interest Income (Expense), NetUSD | — | — | -2,288Source | -1,000Source | -129Source | -4,690Source | -34Source | -1,103Source | -8,240Source | -3,193Source | — | — |
| Labor and Related ExpenseUSD | — | — | 448,084Source | 294,175Source | 501,717Source | 370,401Source | 498,560Source | 335,358Source | 1,879,283Source | 1,500,089Source | 1,387,916Source | 694,108Source |
| Marketing and Advertising ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 11,214Source | 21,149Source |
| Nonoperating Income (Expense)USD | — | — | 69,320Source | 60,101Source | 8,145Source | 39,871Source | 23,065Source | 23,936Source | 169,748Source | 142,613Source | 1,047,587Source | 135,215Source |
| Operating ExpensesUSD | — | — | 2,359,832Source | 2,531,854Source | 2,256,212Source | 1,668,608Source | 2,133,035Source | 2,038,682Source | 8,631,155Source | 7,886,774Source | 5,781,356Source | 2,791,176Source |
| Other IncomeUSD | — | — | 20,258Source | 2,851Source | — | 2,743Source | 2,006Source | 2,714Source | 34,568Source | 9,310Source | 239,542Source | 171,681Source |
| Research and Development ExpenseUSD | — | — | 226,520Source | 178,565Source | 564,480Source | 225,774Source | 346,382Source | 406,288Source | 1,083,522Source | 1,190,884Source | 1,922,000Source | 511,000Source |
| Depreciation, Depletion and Amortization, Nonproduction | — | — | — | — | —Source | — | —Source | — | — | — | — | — |
| Income (Loss) Attributable to Parent, before Tax | — | — | — | —Source | — | — | — | — | — | — | — | — |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | —Source | —Source | —Source | —Source | — | — | — | — | — | — |
Offerings
Registration 333-298744
Registration 333-286711
- Gross proceeds
- 5005000.0
- Net proceeds
- 4604600.0
- Deal price
- 1.3
- Shares
- 3850000
- Offering price
- $1.30
- Ticker
- NXL
Registration 333-283960
Filing attachments
nexalintec_ex99-1.htm · 8-K · 2026-10-01
Exhibit 99.1 Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in Its Transition Toward Commercial Revenue Generation Agreement establishes an initial 100-device commercialization program for the ANVISA-approved Nexalin Sync™ across seven countries and more than 300 million people, with a structured pricing framework and a mechanism for larger strategic transactions with government and private-sec…
Read attachment ↗nexalintech_ex107.htm · S-1 · 2026-09-03
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) N/A Nexalin Technology, Inc. (Exact Name of Registrant as Specified in its Charter) Security Security Fee Amount Proposed Maximum Fee Rate Amount of Type Class Calculation Registered(1) …
Read attachment ↗nexalintec_ex99-1.htm · 8-K · 2026-08-27
EX-99.1 3 nexalintec_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Nexalin Technology Announces Reverse Stock Split HOUSTON - August 27, 2026 - Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), announces that its board of directors has approved a 1-for-30 reverse stock split of the Company’s common stock, to ensure continued compliance with the Nasdaq bid-price rule. The Company’s stockholders approved future reverse stock splits, their timing, and granted the board of directors …
Read attachment ↗nexalintec_ex4-1.htm · 8-K · 2026-08-20
EX-4.1 2 nexalintec_ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT …
Read attachment ↗nexalintec_ex4-2.htm · 8-K · 2026-08-20
EX-4.2 3 nexalintec_ex4-2.htm EXHIBIT 4.2 Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT …
Read attachment ↗nexalintec_ex99-1.htm · 8-K · 2026-05-19
EX-99.1 2 nexalintec_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial Acquisition gives Nexalin control of AI-integrated remote patient-monitoring, clinical data-capture and virtual-care infrastructure already deployed at UCSD HOUSTON, TX, May 19, 2026, Nexalin Technology, Inc. (Nasdaq: NXL) (“Nexalin” or the “Company”), the leader in non-invasiv…
Read attachment ↗